Neurol. praxi. 2026;27(1):64-69

The Great Moravian Franz Gerstenbrand (1924-2017)

prof. MUDr. Petr Kaňovský, CSc., FEAN
Neurologická klinika a Centrum klinických neurověd Lékařské fakulty Univerzity Palackého a Fakultní nemocnice Olomouc

Franz Gerstenbrand (1924-2017) was born in Hof in Mähren to parents who were native South Moravians from the Znaim region; his father worked as a family doctor in Hof. Shortly after little Franz was born, the family returned to South Moravia because doctor Gerstenbrand found a job as a family doctor in Unter Tannowitz. This is where Franz Gerstenbrand spent the days of his childhood and youth, graduating from a grammar school in Nikolsburg. Immediately after graduation, he had to enlist in the army, was assigned to the air force, and spent the rest of the war as an operational fighter pilot. After the war ended, he was captured by the Western Allies and, after being released from captivity in 1946, he returned to South Moravia where his family could no longer be found. Having searched for a longer period of time, he found his parents in Ebreichsdorf near Vienna where they later settled permanently. Gerstenbrand was accepted to the University of Vienna to study medicine and after graduation in 1950 he started working at the Department of Neurology and Psychiatry at AKH under the supervision of Professor Hoff. In 1967, he was habilitated on the basis of his thesis on apallic syndrome, in 1973 he was appointed as extraordinary professor, and in 1975 he became a full university professor. In 1975, he left the clinic in Vienna to become head of the neurology department at the Rosenhügel Municipal Hospital in Vienna. In 1976, he was invited to take over the university clinic in Innsbruck, which he accepted. Within a few years, he built a modern neurology centre on the foundations of a small provincial institute that soon became a benchmark for new European neurology. He had been head of the clinic in Innsbruck until 1995, when he retired. He returned to Vienna where he worked again at the Rosenhügel Hospital as consultant, and at the Karl Landsteiner Institute he pursued his late-career research topic, cosmic neurology. However, his main interest during these years was the leadership of the European Federation of Neurological Societies, of which he was president for six years and a member of the executive committee for another twelve years. He died in Vienna on 30 June 2017 at the venerable age of 93.

Keywords: Franz Gerstenbrand, South Moravia, Innsbruck, apalic syndrome.

Published: March 11, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kaňovský P. The Great Moravian Franz Gerstenbrand (1924-2017). Neurol. praxi. 2026;27(1):64-69.
Download citation

References

  1. Barbeau A, Duvoisin RC, Gerstenbrand F, et al. Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. J Neurol Sci. 1981;51:311-27. Go to original source...
  2. Battistin L, Provinciali L, Federico A. In memoriam of Franz Gerstenbrand (1924-2017). Neurol Sci. 2017: 1559-1560. Go to original source...
  3. Benke T, Koserenko O, Watson NV, Gerstenbrand F. Space and cognition: the measurement of behavioral functions during a 6-day space mission. Aviat Space Environ Med. 1993;64:376-9.
  4. Berger M, Gerstenbrand F, De Col C, et al. Bewegungsstörungen in der Schwerelosigkeit [Movement disorders in weightlessness]. Wien Med Wochenschr. 1993;143:614-9.
  5. Berger M, Lechner-Steinleitner S, Kozlovskaya I, et al. The effect of head-to-trunk position on the direction of arm movements before, during, and after space flight. J Vestib Res. 1998;8:341-54. Go to original source...
  6. Birbamer G, Ransmayr G, Gerstenbrand F, et al. Therapeutic experiences with an abeorphine derivative in Parkinson's disease. Adv Neurol. 1987;45:591-2.
  7. Deuschl G, Poewe W. Franz Gerstenbrand - Obituary. Eur J Neurol. 2017;24:1089-1090. Go to original source...
  8. Gerstenbrand F. Das traumatische appalische syndrome: klinik, morphologie, pathophysiologie und behandlung. Springer, Wien 1967. Go to original source...
  9. Gerstenbrand F. The Symptomatology of the Apallic Syndrome. In: Peters G, Dalle Ore G, Gerstenbrand F, Lücking CH, Peters UH (eds.) The Apallic Syndrome. Monographien aus dem Gesamtgebiete der Psychiatrie, vol 14. Springer, Berlin, Heidelberg 1977. Go to original source...
  10. Gerstenbrand F, Avenarius HJ, Preissler HP. The Apallic Syndrome in Metabolic Disorders of the Brain. In: Peters G, Dalle Ore G, Gerstenbrand F, Lücking CH, Peters UH (eds.) The Apallic Syndrome. Monographien aus dem Gesamt­gebiete der Psychiatrie, vol 14. Springer, Berlin, Heidelberg 1977 (a). Go to original source...
  11. Gerstenbrand F, Lücking CH. The Rehabilitation of Patients with Apallic Syndrome in the Therapeutic Community. In: Peters G, Dalle Ore G, Gerstenbrand F, Lücking CH, Peters UH (eds.) The Apallic Syndrome. Monographien aus dem Gesamtgebiete der Psychiatrie, vol 14. Springer, Berlin, Heidelberg 1977. Go to original source...
  12. Gerstenbrand F, Lackner F, Lücking CH. A Rating Sheet to Monitor Apallic Syndrome Patients. In: Peters G, Dalle Ore G, Gerstenbrand F, Lücking CH, Peters UH (eds) The Apallic Syndrome. Monographien aus dem Gesamtgebiete der Psychiatrie, vol 14. Springer, Berlin, Heidelberg 1977 (b). Go to original source...
  13. Gerstenbrand F, Klingler D, Pfeiffer B. Der essentielle Tremor, Phänomenologie und Epidemiologie [Essential tremor: phenomenology and epidemiology]. Nervenarzt. 1982;53:46-53.
  14. Gerstenbrand F, Ransmayr G, Poewe W. Deprenyl (selegiline) in combination treatment of Parkinson's disease. Acta Neurol Scand Suppl. 1983;95:123-6. Go to original source...
  15. Gerstenbrand F, Ransmayr G. Nosography of Parkinson's disease. J Neural Transm Suppl. 1986;22:119-28.
  16. Gerstenbrand F, Poewe W. Dopaminergic-peptidergic interactions in extrapyramidal disorders: a review of the clinical evidence. Adv Neurol. 1987;45:67-73.
  17. Gerstenbrand F, Karamat E. Adolf Hitler's Parkinson's disease and an attempt to analyse his personality structure. Eur J Neurol. 1999; 6: 121-7 Go to original source...
  18. Golaszewski S. Franz Gerstenbrand, Dr. Med. (1924-2017). Neurology. 2017;89:1544-45. Go to original source...
  19. Mechtcheriakov S, Berger M, Molokanova E, et al. Slowing of human arm movements during weightlessness: the role of vision. Eur J Appl Physiol. 2002;87:576-83. Go to original source...
  20. Poewe W, Gerstenbrand F. Klinische Subtypen der Parkinson-Krankheit [Clinical subtypes of Parkinson disease]. Wien Med Wochenschr. 1986; 136: 384-7.
  21. Poewe W, Kleedorfer B, Gerstenbrand F, Oertel W. Subcutaneous apomorphine in Parkinson's disease. Lancet. 1988;8591:943. Go to original source...
  22. Schwarzenberg T. Mein Weg Zurück ins Leben. Ibera Verlag, Wien. 1995.
  23. Selzer ME. In Memoriam Prof. Dr. Med. Dr. H.c. mult. Framz Gerstenbarnd: Em. Professor of Neurology at the University of Innsbruck. Neurorehab Neur Repair. 2017;31:691-692.
  24. Tomilovskaya ES, Berger M, Gerstenbrand F, et al. Effects of long- duration space flights on characteristics of the vertical gaze fixation reaction. J Vestib Res. 2013;23:3-12 Go to original source...
  25. Tomilovskaya ES, Berger M, Gerstenbrand F, Kozlovskaya IB. Alterations of characteristics of horizontal gaze fixation reaction in long-term space flights. J Gravit Physiol. 2007;14:P79-80.
  26. Wutzl B, Unterrainer AF, Kronbichler M, et al. Functional magnetic resonance imaging under anaesthesia of a patient with severe chronic disorders of consciousness. Clin Neurol Neurosurg. 2018;172:96-98. Go to original source...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.